| IBIOM |
A comparative genomics approach for the study of the spatio-temporal distribution of SARS-CoV-2
| Comparative genomics; Genomic surveillance; Phylogeographic analyses; Bioinformatics | M. Chiara |
| IBIOM |
A novel methodology for accurate detection and quantification of individual SARS-CoV-2 sub-genomic RNAs by droplet digital PCR (ddPCR) aimed at setting up an effective COVID-19 diagnostic strategy
| SARS-Cov2, ddPCR, sgRNA, quantification | G. Pesole, A.M. D’Erchia, A. Oranger, C. Manzari |
| IFT |
Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patients: a phase II clinical study
| Interferon-beta, Immunomodulation, clinical study, COVID-19 | G. Sconocchia |
| IBIOM |
Building a digital space for Covid-19 research
| Galaxy, Laniakea, COVID-19 | M. Tangaro |
| IBB |
CA IX as target for the development of new anti-tumour drugs
| Antitumor drugs, hypoxia, drug design | G. De Simone |
| IBIOM |
Comparative genomics provides an operational classification system and reveals early emergence and biased spatio-temporal distribution of SARS-CoV-2
| Comparative genomics of SARS-Cov2, evolution of viral types | G. Pesole |
| ITB |
CoV-ncRNASig: a bioinformatic tool for the prediction of smallRNA interference between Coronaviruses and humans
| non-codingRNA, RNA-interference, host-virus-interaction | A. Consiglio, D. Catalano, G. Grillo, F. Licciulli, D. D’Elia |
| IFC |
Design of an optimized path for data flow and management of patients characterized by clinical and radiological features compatible with COVID-19 (OPTIMISED)
| COVID-19, lung ultrasound, artificial intelligence | F. Faita, L. Gargani |
| IFC |
Development of composite polymeric matrices, containing metal nanoparticles and / or essential oils, with antiviral properties against VIRUS SARS-CoV-2 Sars-Cov-2 (STOP-VIRUS)
| polymeric matrices, coating, nanoparticles, essential oil, antiviral, sars-Cov-2 | G. Soldani |
| IN |
Disclosing Covid-19 gateways to the brain: viral trafficking based on in vitro models and patients’ samples
| COVID-19, viral trafficking, cellular imaging, olfactory system, visual system | C. Di Primio |
| ITB |
EPICOVID19 - National Epidemiological Survey on COVID-19
| Web-based survey; COVID-19; Epidemiological study | F. Adorni, F. Prinelli |
| IFC |
Evaluation of MULTIsystemic disease and immunological predisposition in patients with previous COVID19 (MULTICOVID)
| COVID-19, multiorgan disease, immune response, Magnetic Resonance Imaging | Lamia Ait Ali |
| IFC |
Exploiting RNA editing against the SARS-CoV-2: hacking the virus to identify molecular targets
| RNA Editing, Viral Restriction, Viral Evolution, Bioinformatic Analysis | S. Conticello |
| IGB |
Genomics to fight the emerging COVID19 pandemic
| SARS-CoV-2, genomics, third generation sequencing | V. Colonna, G. Damaggio, F. Villani |
| IEOS |
Identification of cytokine signature in first and second wave of COVID-19 pandemics
| cytokines, diagnostics, disease progression | V. D’Esposito |
| IRGB |
Idiopatic Pulmonary Fibrosis genomic profile and its molecular correlation with interstitial fibrosis induced by SARS-CoV2 and Pulmonary Adenocarcinoma
| Idiopathic Pulmonary Fibrosis (IPF), Lung Adenocarcinoma (LAC), Covid-19 Pulmonary Fibrosis (PF) | I. Persico, M.C. Sini, S. Casula |
| IBB |
Intrinsically disordered proteins and human diseases
| Tumor, disorder, natively unfolded | S.M. Monti, E. Langella |
| IFC |
LOST IN TOSCANA - Behavioral changes and psychological distress after the lockdown for Covid-19 in Tuscany, Lombardy and Italy: LOckdown and lifeSTyles IN Tuscany
| consumptions, lifestyles, psychological distress, lockdown | S. Molinaro |
| IFC |
Lung ultrasound to predict COVID-19 pneumonia: a multicenter descriptive study
| Lung ultrasound; COVID-19; light beam; interstitial pneumonia | L. Gargani |
| IBB |
Molecular and biochemical human diseas
| CAF1, DNA, nucleosome assembly | S.M. Monti, E. Langella |
| IBB |
Monitoraggio domiciliare di parametri fisiopatologici di pazienti fragili
| Telemedicina, wearable medical devices, New Technologies for Covid-19 | M. Magliulo |
| IBB |
Preclinical multimodal molecular imaging
| preclinical imaging, molecular imaging, mouse models | L. Auletta, M. Mancini |
| IBB |
Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives
| Protein Protein Interaction; fibrils; NMR spectroscopy; thermophoresis; Phox2B | E. Pedone, L. Pirone |
| IBB |
Quantitative Magnetic Resonance Imaging
| Relaxometry, quantitative MRI, magnetic susceptibility | G. Palma, S. Monti |
| IFC |
Research contract with Texcar SPA for the Development of Antiviral Textile Products
| Textile, Antiviral, Sars-Cov-2, copper | G. Soldani |
| IRGB |
Role of genetic variants at ACE2 and TMPRSS2 genes involved in SARS-CoV-2 infection in human phenotypes
| ACE2, TMPRSS2, genetics, COVID19 | S. Sanna |
| IBB |
Search for genomic biomarkers for vitamin D response in patients with Covid-19 and IBD
| Inflammatory Bowel Disease, Vitamin D, SARS-CoV-2, RNA-seq, Extracellular vesicles | S. Fagoonee |
| IBB |
The analysis of conservative and non-conservative amino acid mutations in SARS- CoV-2 variants provides insights into the early evolution of the virus in humans
| SARS-CoV-2, substitution matrices, amino-acid mutations | L. Vitagliano, N. Balasco |
| IGM |
The DDX family RNA helicases and SARS-COV-2: targeting host-virus interactions
| RNA helicase DDX3X, broad spectrum antivirals, hst pathogen-interactions | G. Maga |
| IBB |
The fine structure of proteins: detection and implications
| protein structure databases, molecular models, protein conformation | L. Esposito, L. Vitagliano |
| IGB |
The impact of COVID-19 on rare diseases: Incontinentia pigmenti (IP) as a model to improve the knowledgeon both COVID-19 and IP
| COVID-19, Incontinentia pigmenti, INF1 autoimmunity | F. Fusco |
| IBB |
Thermotoga maritima Arginine Binding Protein as a model for protein manipulation and scaffold design
| protein scaffolds; biosensors; crystal structure | A. Ruggiero, G. Smaldone |
| IFC |
TiAssisto Project
| Telemedicine, multipathology, multiparametric monitoring, fragility, Artificial Intelligence, Decision Support System, out of hospital ultrasound, medical imaging, biomedical computing, Covid-19 | L. Pratali |
| IRIB |
TOLEPATI' for COVID-19: Technological innovation at the service of the patient care
| Sars-Cov-2, telemedicine, innovative digital platform | G. Insalaco, E. Pace, G. Pioggia, G. Biamonti |
| IBIOM |
Yeast as a model to study the effect of SARS-CoV-2 non-structural proteins on cell stress response and interactions with cell components
| SARS-CoV-2, positive-strand RNA viruses, Saccharomyces cerevisiae, programmed cell death, cell membranes, replication organelles | S. Giannattasio |